Jci_page_head_homepage_01 Jci_page_head_homepage_02
Marcus D. Säemann, Thomas Weichhart, Maximilian Zeyda, Günther Staffler, Michael Schunn, Karl M. Stuhlmeier, Yuri Sobanov, Thomas M. Stulnig, Shizuo Akira, Alexander von Gabain, Uwe von Ahsen, Walter H. Hörl, Gerhard J. Zlabinger
Published in Volume 115, Issue 2
J Clin Invest. 2005; 115(2):468–475 doi:10.1172/JCI22720
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

Involvement of TLR signaling in APC activation by THP. (A) Immature human DCs were incubated with THP, LPS, or medium, and immunoblotting was performed from whole-cell lysates using antibodies against IRAK-1 and ERK-2, which served as loading control. A representative of 4 independent experiments is shown. (B) Bone marrow–derived murine DCs (BM-DCs) were treated with or without TIRAP/Mal peptide followed by stimulation with THP or LPS. After 18 hours, cell-free supernatants were collected and analyzed by ELISA. (C) Immature human DCs were pretreated with a mAb against TLR4 (HTA125) or a control mAb before addition of LPS or THP. Cell-free supernatants were then collected and analyzed by ELISA. Data are representative of 3 independent experiments. mDCs, monocyte-derived DCs. *Significantly different from the values for stimulated control; P < 0.05.